UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.77 +0.75 (+0.96%) GOLD FUTURES
2,392.20 +32.30 (+1.37%) DOW
39,845.40 +287.29 (+0.73%) Bitcoin GBP
51,675.95 +3,252.22 (+6.72%)
XERS Oct 2024 2.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:27PM EDT. Market open.
| Previous close | 0.4000 |
| Open | 0.4000 |
| Bid | 0.0000 |
| Ask | 0.6500 |
| Strike | 2.00 |
| Expiry date | 2024-10-18 |
| Day's range | 0.4000 - 0.4000 |
| Contract range | N/A |
| Volume | |
| Open interest | 255 |
GuruFocus.comXeris Biopharma Holdings Inc (XERS) Q1 2024 Earnings: Revenue Growth Amidst Challenges
Performance Surpasses Revenue Estimates but Misses on EPS
Insider MonkeyXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript May 9, 2024 Xeris Biopharma Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, everyone, and welcome to the Xeris Biopharma First Quarter 2024 Financial Results Conference Call […]
Simply Wall St.Xeris Biopharma Holdings First Quarter 2024 Earnings: Misses Expectations
Xeris Biopharma Holdings ( NASDAQ:XERS ) First Quarter 2024 Results Key Financial Results Revenue: US$40.6m (up 22...
© 2024 Yahoo. All rights reserved.